E-LIB Suche - Ergebnisse für: Rochlitz, C

1

Pegylated liposomal doxorubicin (PLD) in daily practice—A s..:

Wallrabenstein, T ; Daetwyler, E ; Oseledchyk, A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315717/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Eribulin as first-line treatment in older patients with adv..:

Hasler-Strub, U ; Mueller, A ; Li, Q...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgo.2022.09.001. , 2023

Link: https://serval.unil.ch/n..

3

Targeting immunoliposomes to EGFR-positive glioblastoma:

Kasenda, B ; König, D ; Manni, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741448/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Long-term responders to trastuzumab monotherapy in first-li..:

Schmid, S ; Klingbiel, D ; Aebi, S...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12885-019-6105-3. , 2019

Link: https://serval.unil.ch/n..

5

SAKK 24/09: safety and tolerability of bevacizumab plus pac..:

Rochlitz, C ; Bigler, M ; von Moos, R...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12885-016-2823-y. , 2016

Link: https://serval.unil.ch/n..

6

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-T..:

Romer, A ; Seiler, D ; Marincek, Nicolas...
https://boris.unibe.ch/48317/. , 2014

Link: https://boris.unibe.ch/4..

7

Combination of bevacizumab and 2-weekly pegylated liposomal..:

Rochlitz, C ; Ruhstaller, T ; Lerch, S...
info:eu-repo/semantics/altIdentifier/doi/10.1093/annonc/mdq319. , 2011

Link: https://serval.unil.ch/n..

8

Combination of bevacizumab and 2-weekly pegylated liposomal..:

Rochlitz, C ; Ruhstaller, T ; Lerch, S...
https://boris.unibe.ch/1614/. , 2011

Link: https://boris.unibe.ch/1..

9

MMP-9 as predictive factor for response and progression fre..:

Zaman, K ; Rochlitz, C ; Ruhstaller, T...
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_140190B7EDBB7. , 2010

Link: https://serval.unil.ch/n..

10

hMMP9 as predictive factor for response and progression fre..:

Zaman, K ; Rochlitz, C ; Ruhstaller, T...
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A13A779D3A8D7. , 2010

Link: https://serval.unil.ch/n..

11

Capecitabine in hormone-resistant metastatic prostatic carc..:

Morant, R ; Bernhard, J ; Dietrich, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409680. , 2004

Link: http://www.ncbi.nlm.nih...

12

Infrequent mutation of the tumour-suppressor gene Smad4 in ..:

Mamot, C ; Mild, G ; Reuter, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747552. , 2003

Link: http://www.ncbi.nlm.nih...

13

SMAD4 is a predictive marker for 5-fluorouracil-based chemo..:

Boulay, J-L ; Mild, G ; Lowy, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240. , 2003

Link: http://www.ncbi.nlm.nih...

14

SMAD4 is a predictive marker for 5-fluorouracil-based chemo..:

Boulay, J-L ; Mild, G ; Lowy, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364238. , 2002

Link: http://www.ncbi.nlm.nih...

15

Specific immunotherapy of MUC1-positive adenocarcinomas wit..:

Bizouarne, N ; Squiban, P ; Acres, B...
http://breast-cancer-research.com/content/3/S1/A10. , 2001

Link: http://breast-cancer-res..